JPS5832823A - 脱癌剤 - Google Patents

脱癌剤

Info

Publication number
JPS5832823A
JPS5832823A JP12942681A JP12942681A JPS5832823A JP S5832823 A JPS5832823 A JP S5832823A JP 12942681 A JP12942681 A JP 12942681A JP 12942681 A JP12942681 A JP 12942681A JP S5832823 A JPS5832823 A JP S5832823A
Authority
JP
Japan
Prior art keywords
vitamin
hydroxyvitamin
eliminating agent
cancer
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12942681A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0459298B2 (enExample
Inventor
Tatsuo Suda
立雄 須田
Koji Mizuno
水野　光司
Shinichi Kaiho
晋一 海宝
Fusayo Onoda
小野田　房代
Kiyoshige Ochi
越知　清成
Isao Matsunaga
功 松永
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP12942681A priority Critical patent/JPS5832823A/ja
Publication of JPS5832823A publication Critical patent/JPS5832823A/ja
Publication of JPH0459298B2 publication Critical patent/JPH0459298B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP12942681A 1981-08-20 1981-08-20 脱癌剤 Granted JPS5832823A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12942681A JPS5832823A (ja) 1981-08-20 1981-08-20 脱癌剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12942681A JPS5832823A (ja) 1981-08-20 1981-08-20 脱癌剤

Publications (2)

Publication Number Publication Date
JPS5832823A true JPS5832823A (ja) 1983-02-25
JPH0459298B2 JPH0459298B2 (enExample) 1992-09-21

Family

ID=15009196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12942681A Granted JPS5832823A (ja) 1981-08-20 1981-08-20 脱癌剤

Country Status (1)

Country Link
JP (1) JPS5832823A (enExample)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206524A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206526A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206525A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206521A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206523A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206522A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58208225A (ja) * 1982-05-28 1983-12-03 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58208229A (ja) * 1982-05-28 1983-12-03 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210015A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210014A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210020A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210018A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JP2009525985A (ja) * 2006-02-03 2009-07-16 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー ２５−ヒドロキシビタミンｄ２及び２５−ヒドロキシビタミンｄ３によるビタミンｄ不足及び欠乏の治療
JP2010525050A (ja) * 2007-04-25 2010-07-22 シトクロマ インコーポレイテッド ビタミンｄ不足および欠乏症の治療方法
US9861644B2 (en) 2013-03-15 2018-01-09 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US9918940B2 (en) 2007-04-25 2018-03-20 Opko Renal, Llc Methods for controlled release oral dosage of a vitamin D compound
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US10302660B2 (en) 2008-04-02 2019-05-28 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
US10668089B2 (en) 2006-06-21 2020-06-02 Opko Ireland Global Holdings, Ltd. Method of treating and preventing secondary hyperparathyroidism
US11173168B2 (en) 2016-03-28 2021-11-16 Eirgen Pharma Ltd. Methods of treating vitamin D insufficiency in chronic kidney disease
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
US11801253B2 (en) 2007-04-25 2023-10-31 Opko Renal, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206524A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206526A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206525A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206521A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206523A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58206522A (ja) * 1982-05-26 1983-12-01 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58208225A (ja) * 1982-05-28 1983-12-03 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58208229A (ja) * 1982-05-28 1983-12-03 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210015A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210014A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210020A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS58210018A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
US9943530B2 (en) 2006-02-03 2018-04-17 Opko Renal, Llc Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
JP2009525985A (ja) * 2006-02-03 2009-07-16 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー ２５−ヒドロキシビタミンｄ２及び２５−ヒドロキシビタミンｄ３によるビタミンｄ不足及び欠乏の治療
US11007204B2 (en) 2006-02-03 2021-05-18 Opko Renal, Llc Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
JP2014065751A (ja) * 2006-02-03 2014-04-17 Proventiv Therapeutics Llc ２５−ヒドロキシビタミンｄ２及び２５−ヒドロキシビタミンｄ３によるビタミンｄ不足及び欠乏の治療
US8906410B2 (en) 2006-02-03 2014-12-09 Opko Health, Inc. Oral dosage form of 25-hydroxyvitamin D
US11911398B2 (en) 2006-02-03 2024-02-27 Opko Renal, Llc Treating Vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US10213442B2 (en) 2006-02-03 2019-02-26 Opko Renal, Llc Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US10668089B2 (en) 2006-06-21 2020-06-02 Opko Ireland Global Holdings, Ltd. Method of treating and preventing secondary hyperparathyroidism
US9925147B2 (en) 2007-04-25 2018-03-27 Opko Renal, Llc Method for treating secondary hyperparathyroidism in CKD
US9918940B2 (en) 2007-04-25 2018-03-20 Opko Renal, Llc Methods for controlled release oral dosage of a vitamin D compound
US11801253B2 (en) 2007-04-25 2023-10-31 Opko Renal, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
JP2010525050A (ja) * 2007-04-25 2010-07-22 シトクロマ インコーポレイテッド ビタミンｄ不足および欠乏症の治療方法
US11154509B2 (en) 2007-04-25 2021-10-26 Eirgen Pharma Ltd. Methods for controlled release oral dosage of a vitamin D compound
JP2014055184A (ja) * 2007-04-25 2014-03-27 Cytochroma Inc ビタミンｄ不足および欠乏症の治療方法
US10302660B2 (en) 2008-04-02 2019-05-28 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
US10357502B2 (en) 2013-03-15 2019-07-23 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US11253528B2 (en) 2013-03-15 2022-02-22 Eirgen Pharma Ltd. Stabilized modified release Vitamin D formulation and method of administering same
US10350224B2 (en) 2013-03-15 2019-07-16 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US10300078B2 (en) 2013-03-15 2019-05-28 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US9861644B2 (en) 2013-03-15 2018-01-09 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US12478631B2 (en) 2013-03-15 2025-11-25 Eirgen Pharma Ltd. Stabilized modified release vitamin D formulation and method of administering same
US10493084B2 (en) 2014-08-07 2019-12-03 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11007205B2 (en) 2014-08-07 2021-05-18 Eirgen Pharma Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11738033B2 (en) 2014-08-07 2023-08-29 Eirgen Pharma Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11173168B2 (en) 2016-03-28 2021-11-16 Eirgen Pharma Ltd. Methods of treating vitamin D insufficiency in chronic kidney disease
US12208106B2 (en) 2016-03-28 2025-01-28 Eirgen Pharma Ltd. Methods of vitamin D treatment

Also Published As

Publication number Publication date
JPH0459298B2 (enExample) 1992-09-21

Similar Documents

Publication Publication Date Title
JPS5832823A (ja) 脱癌剤
ES2309069T3 (es) Compuestos de 2-etil y 2-etiliden-19-nor-vitamina d.
DE60219655T2 (de) Oxim-analoga von 1-alpha,25-dihydroxy-vitamin-d3 mit geringer calcemischer wirkung
KR100231809B1 (ko) 1알파-하이드록시 비타민 d4 및 이의 중간체 및 동족체, 및 이를 포함하는 약제학적 조성물
DE68907483T2 (de) Vitamin d analoge.
DE69307929T2 (de) Neuen vitamin d derivate
DE69308852T2 (de) Vitamin d derivate
JPH03501259A (ja) 新規なシクロペンタノ‐ビタミンｄ類似体
DE69316910T2 (de) Neue vitamin d derivate
JPH11506792A (ja) 皮膚疾患治療のためのビタミンｄ４誘導体の使用
JPH02288829A (ja) 骨の損耗の予防又は再生不調症の治療又は予防用薬剤
US20190060456A1 (en) 1-deoxy analogs of vitamin d-related compounds
DE69011872T2 (de) Neue vitamin-d-derivate.
DE69714590T2 (de) Vitamin d analoge verbindungen
DE69712086T2 (de) Vitamin d derivate
Binderup Comparison of calcipotriol with selected metabolites and analogues of vitamin D3: effects on cell growth regulation in vitro and calcium metabolism in vivo
JPS61501088A (ja) ヒドロキシビタミンｄ↓２異性体
US5801164A (en) Methods of treating osteoporosis prophylactically or therapeutically
WO1989010352A1 (en) SIDE CHAIN UNSATURATED 1alpha-HYDROXYVITAMIN D HOMOLOGS
IL97158A (en) Homologous histories of vitamin D in the side chain, processes for their preparation and pharmaceutical preparations containing them
JPH0364498B2 (enExample)
DE3590080C2 (enExample)
TW200800156A (en) 1, 25-dihydroxy, 20-cyclopropyl, 26, 27-deuteroalkyl vitamin D3 compounds and methods of use thereof
US5756488A (en) Composition for improving calcium metabolism
JPS63107931A (ja) ２０−オキサビタミンｄ↓３を有効成分とする医薬